L. Nakopoulou

A. Lazaris, L. Nakopoulou, I. Boletis, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression.

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2007, Histology and Histopathology.

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

M. Dimopoulos, L. Nakopoulou, A. Tzonou, 1998, Human pathology.

An immunohistochemical evaluation of the proteins Wnt1 and glycogen synthase kinase (GSK)‐3β in invasive breast carcinomas

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2013, Histopathology.

The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer

A. Lazaris, I. Giannopoulou, S. Markaki, 2004, Journal of Clinical Pathology.

WNT1 (wingless-type MMTV integration site family, member 1)

L. Nakopoulou, I. Theohari, 2014 .

Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2014, Pathology, research and practice.

Evaluation of Numeric Alterations of Chromosomes 1 and 17 by In Situ Hybridization in Invasive Breast Carcinoma With Clinicopathologic Parameters

I. Giannopoulou, A. Keramopoulos, L. Nakopoulou, 2002, Applied immunohistochemistry & molecular morphology : AIMM.

Prognostic Significance of p53, bcl-2 and EGFR in Carcinoma of the Endometrium

P. Athanassiadou, E. Petrakakou, A. Liossi, 1999, Acta Cytologica.

Immunohistochemical evaluation of nm23‐H1 gene product in transitional cell carcinoma of the bladder

A. Lazaris, L. Nakopoulou, A. Tzonou, 1996, Histopathology.

MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival

L. Nakopoulou, P. Alexandrou, S. Markaki, 2004, Breast Cancer Research and Treatment.

The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1‐MMP) and MMP‐9 according to their localization in invasive breast carcinoma

E. Mylona, A. Keramopoulos, L. Nakopoulou, 2007, Histopathology.

Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography

L. Nakopoulou, M. Souvatzoglou, M. Sotiropoulou, 2004, Breast Cancer Research.

MMP-3 mRNA and MMP-3 and MMP-1 Proteins in Bladder Cancer: A Comparison With Clinicopathologic Features and Survival

A. Lazaris, C. Constantinides, I. Giannopoulou, 2001, Applied immunohistochemistry & molecular morphology : AIMM.

High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma

S. Theocharis, G. Tsourouflis, L. Nakopoulou, 2021, Diagnostics.

MLH1 mismatch repair gene product is associated with apoptotic potential of urothelial bladder carcinomas.

A. Lazaris, N. Kavantzas, L. Nakopoulou, 2006, Anticancer research.

The multifunctional role of the immunohistochemical expression of MMP‐7 in invasive breast cancer

E. Mylona, A. Kapranou, J. Mavrommatis, 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.

I. Giannopoulou, E. Mylona, S. Markaki, 2007, European Journal of Surgical Oncology.

No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs).

P. Davaris, L. Nakopoulou, A. Guialis, 2000, Journal of autoimmunity.

Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer.

E. Mylona, J. Mavrommatis, L. Nakopoulou, 2005, Anticancer research.

Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2006, Anticancer research.

The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.

A. Lazaris, L. Nakopoulou, Christina Zoubouli, 2006, Anticancer research.

Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer.

P. Davaris, C. Constantinides, L. Nakopoulou, 2000, Anticancer research.

Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2009, European Journal of Surgical Oncology.

Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2008, Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS).

Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: An immunocytochemical study

P. Athanassiadou, E. Petrakakou, A. Liossi, 2009, Pathology & Oncology Research.

Diagnostic approach of effusion cytology using computerized image analysis.

P. Athanassiadou, E. Petrakakou, A. Liossi, 2002, Journal of experimental & clinical cancer research : CR.

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.

A. Lazaris, P. Davaris, I. Giannopoulou, 1999, Histopathology.

Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2006, Journal of Clinical Pathology.

Y-box-binding protein 1 (YB1) in breast carcinomas: relation to aggressive tumor phenotype and identification of patients at high risk for relapse.

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2008, Human pathology.

PROGNOSTIC SIGNIFICANCE OF THE CO‐EXPRESSION OF p53 AND c‐erbB‐2 PROTEINS IN BREAST CANCER

A. Lazaris, L. Nakopoulou, G. Theodoropoulos, 1996, The Journal of pathology.

Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.

I. Giannopoulou, E. Mylona, S. Markaki, 2006, Cancer Detection and Prevention.

Epithelioid trophoblastic tumor.

L. Nakopoulou, C. Magkou, A. Rouvas, 2007, Ophthalmology.

Expression patterns of β-catenin in in situ and invasive breast cancer

A. Keramopoulos, L. Nakopoulou, M. Pignatelli, 2001 .

Heat shock protein 70 and HLA-DR molecules tissue expression

C. Kittas, A. Lazaris, L. Nakopoulou, 1995, Diseases of the colon and rectum.

Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype

Eleni Mylona, Ioanna Giannopoulou, I. Giannopoulou, 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Enhanced mRNA expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in breast carcinomas is correlated with adverse prognosis

K. Stefanaki, P. Davaris, I. Giannopoulou, 2002, The Journal of pathology.

Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome.

I. Giannopoulou, L. Nakopoulou, D. Trafalis, 2002, Cancer genetics and cytogenetics.

Immunohistochemical Expression of Caspase-3 as an Adverse Indicator of the Clinical Outcome in Human Breast Cancer

A. Lazaris, K. Stefanaki, L. Nakopoulou, 2002, Pathobiology.

Nestin involvement in tissue injury and cancer - a potential tumor marker?

G. Kouraklis, L. Nakopoulou, W. Weber, 2014, Cellular Oncology.

Thoughts on the Cytopathologist and Cell Culture

Anshu, Carlos F. Villamil, M. Bibbo, 1999, Acta Cytologica.

Contributor Index Volume 43, 1999

Anshu, Carlos F. Villamil, M. Bibbo, 1999, Acta Cytologica.

EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer

S. Theocharis, G. Tsourouflis, L. Nakopoulou, 2022, Diagnostics.

The Potential Role of Calcitonin Gene-Related Peptide (CGRP) in Breast Carcinogenesis and Its Correlation With 99mTc-(V)DMSA Scintimammography

L. Nakopoulou, A. Antsaklis, M. Sotiropoulou, 2007, American journal of clinical oncology.

Non‐endothelial KDR/flk‐1 expression is associated with increased survival of patients with urothelial bladder carcinomas

J. Mavrommatis, L. Nakopoulou, A. Giannopoulos, 2003, Histopathology.

The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2007, Gynecologic oncology.

Nestin involvement in tissue injury and cancer - a potential tumor marker?

G. Kouraklis, L. Nakopoulou, W. Weber, 2014, Cellular Oncology.

Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2013, Histopathology.

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas

I. Giannopoulou, L. Nakopoulou, C. Magkou, 2008, Breast Cancer Research.

The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases‐1 protein overexpression in breast cancer cells

A. Lazaris, I. Giannopoulou, S. Markaki, 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Prognostic significance of phosphorylated STAT‐1 expression in premenopausal and postmenopausal patients with invasive breast cancer

I. Giannopoulou, L. Nakopoulou, P. Rafailidis, 2012, Histopathology.

Tissue immunodetection of c100 hepatitis C virus antigen in major thalassemic patients.

A. Lazaris, P. Davaris, L. Nakopoulou, 1999, Hepato-Gastroenterology.

Exon 8 amplification of epidermal growth factor receptor (EGFR) in invasive breast carcinomas

I. Giannopoulou, L. Nakopoulou, C. Papadimitriou, 2012, Histopathology.

Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer

A. Lazaris, N. Kavantzas, I. Giannopoulou, 2004, Virchows Archiv.

DNA Topoisomerase II-Alpha Immunoreactivity as a Marker of Tumor Aggressiveness in Invasive Breast Cancer

P. Athanassiadou, A. Lazaris, N. Kavantzas, 2000, Pathobiology.

Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.

P. Davaris, I. Giannopoulou, L. Nakopoulou, 1999, Human pathology.

Transitional cell carcinoma arising from a fibroepithelial ureteral polyp in a patient with duplicated upper urinary tract.

G. Rassidakis, L. Nakopoulou, D. Mitropoulos, 1997, The Journal of urology.

Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients

G. Kouraklis, E. Patsouris, S. Theocharis, 2018, Pathology & Oncology Research.

Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas.

L. Nakopoulou, A. Giannopoulos, H. Gakiopoulou, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome

I. Giannopoulou, E. Mylona, S. Markaki, 2006, Breast Cancer Research.

p53 Protein expression and proliferative activity in ductal breast carcinomas

J. Gogas, P. Athanassiadou, L. Nakopoulou, 2000, Cytopathology : official journal of the British Society for Clinical Cytology.

Expression patterns of beta-catenin in in situ and invasive breast cancer.

A. Keramopoulos, L. Nakopoulou, M. Pignatelli, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Correlation of Tissue Inhibitor of Metalloproteinase-2 with Proliferative Activity and Patients’ Survival in Breast Cancer

I. Giannopoulou, J. Mavrommatis, A. Keramopoulos, 2002, Modern Pathology.

Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.

I. Giannopoulou, A. Keramopoulos, L. Nakopoulou, 2002, Histopathology.

PPARγ expression in breast cancer: clinical value and correlation with ERβ

I. Papadaki, I. Giannopoulou, E. Mylona, 2005, Histopathology.

Stromelysin-3 Protein Expression in Invasive Breast Cancer: Relation to Proliferation, Cell Survival and Patients’ Outcome

Ioanna Giannopoulou, P. Athanassiadou, I. Giannopoulou, 2002, Modern Pathology.

Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer.

K. Pavlakis, L. Nakopoulou, S. Sakellariou, 2008, Anticancer research.

Transcription Factor Sp1 Expression Is Upregulated in Human Glomerulonephritis: Correlation with pSmad2/3 and p300 Expression and Renal Injury

T. Kassimatis, I. Giannopoulou, L. Nakopoulou, 2010, Renal failure.